Shandong Xiantan (002746.SZ): Xiantan Holdings plans to increase its holdings of the company's shares by 15 million to 20 million yuan.
Xiantan Co., Ltd. (002746.SZ) announced that the company recently received a letter from its controlling shareholder and chairman, Mr. Wang Shouchun...
Shandong Xiantan (002746.SZ) issued an announcement, stating that the company recently received a notification from its controlling shareholder and chairman, Mr. Wang Shouchun, and Mr. Wang Shouchun's acting in concert party Shandong Xiandong Holdings Co., Ltd. ("Xiandong Holdings"). It was reported that Xiandong Holdings had purchased 1.82 million shares of the company through block trading on January 10, 2025, representing 0.21% of the company's total share capital.
Xiandong Holdings plans to continue to increase its holdings of the company's shares through the Shenzhen Stock Exchange trading system for a period of 6 months starting from January 10, 2025, using methods including but not limited to block trading. The total amount of additional shares to be acquired is expected to be no less than RMB 15 million and no more than RMB 20 million (including the amount already purchased in this transaction which is RMB 9.989 million).
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025